Current recommendations What is the clinician to do?

Recent findings have helped to clarify the benefits and risks of menopausal hormone therapy and have provided insights to improve clinical decision making. Personalized risk assessment offers promise for improving treatment safety.

Like Comment

Authors

JoAnn Manson, M.D., Dr.P.H.

Volume 101, Issue 4, Pages 916-921

Abstract

Recent findings have helped to clarify the benefits and risks of menopausal hormone therapy and have provided insights to improve clinical decision making. Personalized risk assessment offers promise for improving treatment safety.

Read the full text at: http://www.fertstert.org/article/S0015-0282(14)00196-4/fulltext


Fertility and Sterility

Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders. The journal publishes juried original scientific articles in clinical and laboratory research relevant to reproductive endocrinology, urology, andrology, physiology, immunology, genetics, contraception, and menopause. Fertility and Sterility® encourages and supports meaningful basic and clinical research, and facilitates and promotes excellence in professional education, in the field of reproductive medicine.

No comments yet.